Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00016Erythropoietin1 / 2Completed1
DB00480Lenalidomide1 / 2Completed1